AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered, structured, and analyzed by LLMs. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Australian Entrepreneur Uses AI and AlphaFold to Create First Bespoke Cancer Vaccine for a Dog
Sydney tech entrepreneur Paul Conyngham used ChatGPT and Google DeepMind's AlphaFold to help design a personalized mRNA cancer vaccine for his dog Rosie after conventional treatments failed. Working with UNSW researchers, the vaccine was created in under two months and significantly shrank most of Rosie's tumors.
AI Cracks the Rare-Disease Diagnostic Odyssey
A new Nature-backed advance spotlights DeepRare, an AI system designed to generate ranked rare-disease diagnoses by combining clinical data, genetic information and literature evidence. The story matters because rare-disease diagnosis is one of medicine’s longest-standing bottlenecks, and explainable ranking could make AI more usable in specialist workflows.
AI in Drug Discovery: 2025 in Review — Insilico Medicine Hits Phase IIa Milestone
Insilico Medicine achieved the first positive Phase IIa results for a fully AI-designed drug, while the Recursion-Exscientia merger created an end-to-end AI drug discovery platform. Over 200 AI-discovered drugs are now in development.
Predictive Medicine Moves Closer as AI Models Forecast More Than 1,000 Diseases
Nature Biotechnology reports that AI tools are increasingly able to use clinical records and current health data to predict disease onset and treatment outcomes across a vast number of conditions. The shift reframes AI in healthcare from reactive support toward earlier risk stratification and preventive care.
Stanford's SleepFM Predicts Over 100 Disease Risks from a Single Night's Sleep Data
Stanford Medicine researchers developed SleepFM, an AI model trained on nearly 600,000 hours of sleep data that can predict a person's risk for over 100 health conditions — including Parkinson's, dementia, and cancers — from one night of polysomnography.
Five Years On, AlphaFold Shows Why Science May Be AI's Killer App
Five years after its debut, Google DeepMind's AlphaFold has been used by over 3 million researchers in 190+ countries. Fortune examines how it has become AI's most impactful real-world application in science and healthcare.
Google DeepMind CEO Says AI-Designed Drugs Are Entering Clinical Trials
Demis Hassabis announced that pharmaceutical drugs designed by AI at Isomorphic Labs are entering clinical trials, marking a new chapter in AlphaFold's journey from protein structure prediction to active drug design.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
Claude analyzes each source, extracts key information, and produces structured articles with categories, tags, and analytical context.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.